IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $28,793,000 | -43.9% | 2,173,022 | +0.3% | 0.02% | -44.4% |
Q3 2016 | $51,354,000 | -28.0% | 2,166,825 | -12.5% | 0.03% | -28.9% |
Q2 2016 | $71,352,000 | -3.8% | 2,475,482 | +6.9% | 0.04% | -2.6% |
Q1 2016 | $74,173,000 | -29.9% | 2,316,406 | -6.4% | 0.04% | -27.8% |
Q4 2015 | $105,778,000 | -10.0% | 2,473,698 | -25.9% | 0.05% | -6.9% |
Q3 2015 | $117,531,000 | -23.4% | 3,337,933 | -0.1% | 0.06% | -17.1% |
Q2 2015 | $153,430,000 | -2.3% | 3,341,232 | -0.2% | 0.07% | -1.4% |
Q1 2015 | $156,980,000 | +97.2% | 3,349,284 | +33.3% | 0.07% | +97.2% |
Q4 2014 | $79,615,000 | +318.3% | 2,513,082 | +213.0% | 0.04% | +300.0% |
Q3 2014 | $19,034,000 | -16.1% | 802,808 | +6.1% | 0.01% | -10.0% |
Q2 2014 | $22,685,000 | +111.0% | 756,406 | +85.9% | 0.01% | +100.0% |
Q1 2014 | $10,750,000 | -45.7% | 406,898 | -48.3% | 0.01% | -50.0% |
Q4 2013 | $19,801,000 | +40.7% | 787,613 | +14.8% | 0.01% | +42.9% |
Q3 2013 | $14,069,000 | +5.3% | 685,947 | +2.4% | 0.01% | -12.5% |
Q2 2013 | $13,360,000 | – | 669,731 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |